India, Nov. 7 -- In India, which has the world's third-largest number of overweight adults and over 77 million people with Type 2 diabetes, weight-loss drugs are on a boom. Mounjaro, a tirzepatide marketed by American drugmaker Eli Lilly, reportedly became the second-highest selling drug in India in six months. And doctors, mostly endocrinologists, are flooded with queries about weight loss through GLP-1 medications. It's a trend that worries India's Pilates pioneer Yasmin Karachiwala, who has over three decades of experience in the wellness world. A celebrity fitness trainer to a brigade of Bollywood stars, she says people must be wary of the likely side effects, including muscle loss.

In an exclusive interview with Health Shots, when Y...